IPO Price History
Closed
Par Drugs and Chemicals Limited logo

Par Drugs and Chemicals Limited IPO

SME IPOListedPARNSE
Current Market Price (CMP)
₹103.43(-16.59%)
Current Price (CMP)
₹103.43(-16.59%)

Live Market Quote

Listing Price & Gain
₹142.90(+15.24%)

Day 1 Exchange Open

IPO Issue Price
₹124

Band: ₹51

Total Subscription
5.35x

Overall Bid Demand

Total Issue Size
—

Gross Public Offer

IPO Schedule & Key Dates

IPO Bidding Opens
03 May 2019
IPO Bidding Closes
08 May 2019
Allotment & Refunds
Completed
Exchange Listing Day
16 Sept 2021

IPO Subscription Status

Breakdown of institutional, high-net-worth, and retail bidding demand

Overall Demand: 5.35x
Investor CategorySubscriptionDemand Scale
Qualified Institutional Buyers (QIB)—
Non-Institutional Investors (NII / HNI)—
Retail Individual Investors (RII)—
Total Subscription5.35x
Updated as on null

Listing Day & Return Performance

Listing Day Gain+15.24%
₹124 (Issue) → ₹142.90 (List)
Per share profit: +₹18.90
Holding Return (Till Date)-16.59%
₹124 (Issue) → ₹103.43 (CMP)
Net gain per share: ₹-20.57
Post-Listing Performance (Listing Day → Today):-27.62%

About Par Drugs and Chemicals Limited IPO

Par Drugs and Chemicals Limited is an Indian public offering categorized under the SME (Small and Medium Enterprise) segment. The public issue opened for bidding on 03 May 2019 and concluded on 08 May 2019, offering equity shares to institutional, non-institutional, and retail investors with an indicative price band of ₹51.

During the bidding window, Par Drugs and Chemicals Limited recorded an overall subscription of 5.35 times. Institutional investors (QIB) subscribed —, non-institutional high-net-worth investors (NII) subscribed —, and retail individual investors (RII) bid — their reserved quota.

The equity shares of Par Drugs and Chemicals Limited officially debuted on the stock exchanges on 16 Sept 2021 at an opening listing price of ₹142.90, delivering a listing day return of +15.24% (premium) over the final issue price. As per the latest market data, the stock trades at ₹103.43, representing an overall decline of -16.59% since its IPO allotment.

Frequently Asked Questions

What was the issue price or price band of Par Drugs and Chemicals Limited IPO?
The issue price of Par Drugs and Chemicals Limited IPO was fixed at ₹124 per equity share. The indicative bidding price band was ₹51.
What were the open, close, and listing dates for Par Drugs and Chemicals Limited IPO?
Par Drugs and Chemicals Limited IPO opened on 03 May 2019, closed on 08 May 2019, listed on 16 Sept 2021.
How much was Par Drugs and Chemicals Limited IPO subscribed?
The IPO received an overall subscription of 5.35 times. Category-wise, QIBs subscribed —x, NIIs subscribed —x, and Retail investors subscribed —x.
What was the listing price and listing gain of Par Drugs and Chemicals Limited IPO?
Par Drugs and Chemicals Limited IPO listed on the stock exchange at ₹142.90, delivering a listing gain of 15.24% compared to the IPO issue price of ₹124.
Is Par Drugs and Chemicals Limited IPO a Mainboard or SME IPO?
Par Drugs and Chemicals Limited IPO is a SME IPO listed on the SME platform of NSE.
What is the current return of Par Drugs and Chemicals Limited IPO since its IPO?
At the latest market quote of ₹103.43, Par Drugs and Chemicals Limited IPO has generated an all-time return of -16.59% since its initial public offering.

Related SME IPOs (2021)

VIVO
Vivo Collaboration Solutions Limited
₹82+333.05%
UNITEDPOLY
United Polyfab Gujarat Limited
₹17-89.76%
HECPROJECT
HEC Infra Projects Limited
₹38-3.03%
FOCE
Foce India Limited
₹225-58.33%